PYPD
PYPD
NASDAQ · Pharmaceuticals

Polypid Ltd

$5.38
-0.01 (-0.19%)
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +600.9% upside
Low Target $24.55
Average Target $37.71
High Target $48.03
Current Price $5.38
Current
$5.38
Target
$37.71
$24.55 $37.71 avg $48.03
Scenario Analysis
Bear Case
$24.55
356.3%
Low target
Base Case
$37.71
+600.9%
Avg target
Bull Case
$48.03
+792.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$5.84
-7.9% from high
52-Week Low
$3.50
+53.7% from low
Target vs 52W High
$37.71
+545.7% vs high
Next Earnings Report
Nov 11, 2026 · Before Market Open
4d
until earnings
EPS Est: $0.06
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +155.6%